115 related articles for article (PubMed ID: 3954379)
1. [Phase II study of THP (2''R)-4'-0-tetrahydropyranyladriamycin) in breast cancer].
Abe O; Enomoto K; Tominaga T; Kasai Y; Soejima S; Kasai M; Izuo M; Yoshida M; Kubo K; Terasawa T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):578-85. PubMed ID: 3954379
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
Saito T; Kasai Y; Wakui A; Furue H; Majima H; Nitani H; Niijima T; Takeda C; Abe O; Koyama Y
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850
[TBL] [Abstract][Full Text] [Related]
3. [Phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in gastrointestinal cancer].
Takenaka K; Tamada R; Hiramoto Y; Inokuchi K; Saku M; Oka N; Kano T; Noda S; Nagasaki S; Toda T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2155-60. PubMed ID: 4062315
[TBL] [Abstract][Full Text] [Related]
4. [A randomized controlled study of (2'' R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer].
Abe O; Tominaga T; Enomoto K; Abe R; Iino Y; Koyama H; Fujimoto M; Nomura Y; Tanaka T
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2160-8. PubMed ID: 3717960
[TBL] [Abstract][Full Text] [Related]
5. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group].
Niijima T; Koyanagi T; Sakashita S; Origasa S; Akaza H; Machida T; Koiso K; Rinsho K; Aso Y; Suzuki K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104
[TBL] [Abstract][Full Text] [Related]
6. [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].
Kimura K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):368-75. PubMed ID: 3947112
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of (2''R)-4'-O-tetrahydropyranyldoxorubicin (THP) in patients with advanced gastrointestinal cancer--a report of the Tohoku THP Study Group].
Wakui A; Yokoyama M; Yoshida Y; Kikuchi Y; Osawa I; Masamune O; Matsuoka T; Sato S; Kikuchi K; Shoji T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1032-7. PubMed ID: 3963848
[TBL] [Abstract][Full Text] [Related]
8. [Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].
Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1669-74. PubMed ID: 6591857
[TBL] [Abstract][Full Text] [Related]
9. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].
Nakada H; Ogawa M; Miyamoto H; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Adachi K; Okada Y
Gan To Kagaku Ryoho; 1984 Jan; 11(1):138-42. PubMed ID: 6696455
[TBL] [Abstract][Full Text] [Related]
10. [Phase II study of (2" R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with advanced or recurrent gastric cancer. Clinical study group of THP for gastric cancer in Japan].
Nakao I; Wakui A; Hattori T; Sugimachi K; Saito T
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1325-32. PubMed ID: 2069402
[TBL] [Abstract][Full Text] [Related]
11. [A phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with head and neck cancer].
Takeda C
Gan To Kagaku Ryoho; 1986 May; 13(5):1970-9. PubMed ID: 3707155
[TBL] [Abstract][Full Text] [Related]
12. [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].
Wakui A; Yokoyama M; Konno K; Nakai Y; Sakano T; Koyama Y; Imamura Y; Nakajima O; Niijima T; Akaza H
Gan To Kagaku Ryoho; 1985 Jan; 12(1):118-24. PubMed ID: 3966806
[TBL] [Abstract][Full Text] [Related]
13. [Phase II study of epirubicin on breast cancer: a cooperative group study].
Tominaga T; Kitamura M; Nomura Y; Abe O; Enomoto K; Ikeda T; Izuo M; Iino Y; Taguchi T; Tamura K
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2187-92. PubMed ID: 3459397
[TBL] [Abstract][Full Text] [Related]
14. [Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer].
Shimizu T; Iwasa T; Koike S; Nakamura T; Kanai T; Komatsu D
Gan To Kagaku Ryoho; 2003 Jan; 30(1):105-9. PubMed ID: 12557713
[TBL] [Abstract][Full Text] [Related]
15. [Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy].
Takagi T; Oguro M; Iwabuchi K
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1450-6. PubMed ID: 6588924
[TBL] [Abstract][Full Text] [Related]
16. [A randomized phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin and adriamycin in combination with vincristine and ACNU in small cell lung cancer--THP-ADM, VCR, ACNU vs ADM, VCR, ACNU].
Hino M; Kobayashi K; Kurane S; Nukariya N; Yamano Y; Hasegawa K; Tsuboi E; Niitani H
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3143-8. PubMed ID: 2551250
[TBL] [Abstract][Full Text] [Related]
17. [Phase II study of THP patients with gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hada Y; Hosoma S; Hatayama T; Ogawa Y; Iwamori S; Nagata N
Gan To Kagaku Ryoho; 1986 Feb; 13(2):362-7. PubMed ID: 3947111
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative intra-arterial chemotherapy with THP-ADR for locally advanced breast cancer].
Mukai S; Fujisaki T; Sato N
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1542-5. PubMed ID: 7574754
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
Miller AA; Schmidt CG
Cancer Res; 1987 Mar; 47(5):1461-5. PubMed ID: 3815348
[TBL] [Abstract][Full Text] [Related]
20. An oriented phase II trial of THP-adriamycin in breast carcinoma.
Mathé G; Umezawa H; Oka S; Misset JL; Brienza S; de Vassal F; Musset M; Ribaud P; Tapiero H
Biomed Pharmacother; 1986; 40(10):376-9. PubMed ID: 3580506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
